Active Pharmaceutical Ingredients Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Active Pharmaceutical Ingredients Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report Code: KNJ554161 | No. of Pages: 156 | Category: Pharmaceuticals and Healthcare
Publisher: 99Strategy | Date of Publish: Nov-2020
Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Active Pharmaceutical Ingredients market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Active Pharmaceutical Ingredients market segmented into
    Synthetic APIs
    Biotech APIs

Based on the end-use, the global Active Pharmaceutical Ingredients market classified into
    CNS
    Cardiovascular
    Genitourinary/Hormonal Drugs
    Respiratory
    Rheumatology
    Diabetes
    Oncology
    Others

Based on geography, the global Active Pharmaceutical Ingredients market segmented into
    North America [U.S., Canada, Mexico]
    Europe [Germany, UK, France, Italy, Rest of Europe]
    Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
    South America [Brazil, Argentina, Rest of Latin America]
    Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
    Teva
    Mylan
    DSM
    Aurobindo Pharma
    Aspen
    Novartis
    BASF
    Pfizer
    Huahai Pharmaceutical
    Hisun Pharmaceutical
    Sun Pharmaceutical Industries
    Zhejiang Medicine
    Dr. Reddy’s Laboratories
    Zhejiang NHU
    Bayer
    NCPC
    AbbVie
    Shandong Xinhua Pharmaceutical
    Northeast Pharm
    Harbin Pharmaceutical
    LKPC
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS INDUSTRY
    2.1 Summary about Active Pharmaceutical Ingredients Industry
    2.2 Active Pharmaceutical Ingredients Market Trends
        2.2.1 Active Pharmaceutical Ingredients Production & Consumption Trends
        2.2.2 Active Pharmaceutical Ingredients Demand Structure Trends
    2.3 Active Pharmaceutical Ingredients Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 Synthetic APIs
        4.2.2 Biotech APIs
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 CNS
        4.3.2 Cardiovascular
        4.3.3 Genitourinary/Hormonal Drugs
        4.3.4 Respiratory
        4.3.5 Rheumatology
        4.3.6 Diabetes
        4.3.7 Oncology
        4.3.8 Others
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 Synthetic APIs
        5.2.2 Biotech APIs
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 CNS
        5.3.2 Cardiovascular
        5.3.3 Genitourinary/Hormonal Drugs
        5.3.4 Respiratory
        5.3.5 Rheumatology
        5.3.6 Diabetes
        5.3.7 Oncology
        5.3.8 Others
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 Synthetic APIs
        6.2.2 Biotech APIs
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 CNS
        6.3.2 Cardiovascular
        6.3.3 Genitourinary/Hormonal Drugs
        6.3.4 Respiratory
        6.3.5 Rheumatology
        6.3.6 Diabetes
        6.3.7 Oncology
        6.3.8 Others
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 Synthetic APIs
        7.2.2 Biotech APIs
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 CNS
        7.3.2 Cardiovascular
        7.3.3 Genitourinary/Hormonal Drugs
        7.3.4 Respiratory
        7.3.5 Rheumatology
        7.3.6 Diabetes
        7.3.7 Oncology
        7.3.8 Others
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 Synthetic APIs
        8.2.2 Biotech APIs
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 CNS
        8.3.2 Cardiovascular
        8.3.3 Genitourinary/Hormonal Drugs
        8.3.4 Respiratory
        8.3.5 Rheumatology
        8.3.6 Diabetes
        8.3.7 Oncology
        8.3.8 Others
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 Synthetic APIs
        9.2.2 Biotech APIs
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 CNS
        9.3.2 Cardiovascular
        9.3.3 Genitourinary/Hormonal Drugs
        9.3.4 Respiratory
        9.3.5 Rheumatology
        9.3.6 Diabetes
        9.3.7 Oncology
        9.3.8 Others
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Teva
        10.1.2 Mylan
        10.1.3 DSM
        10.1.4 Aurobindo Pharma
        10.1.5 Aspen
        10.1.6 Novartis
        10.1.7 BASF
        10.1.8 Pfizer
        10.1.9 Huahai Pharmaceutical
        10.1.10 Hisun Pharmaceutical
        10.1.11 Sun Pharmaceutical Industries
        10.1.12 Zhejiang Medicine
        10.1.13 Dr. Reddy’s Laboratories
        10.1.14 Zhejiang NHU
        10.1.15 Bayer
        10.1.16 NCPC
        10.1.17 AbbVie
        10.1.18 Shandong Xinhua Pharmaceutical
        10.1.19 Northeast Pharm
        10.1.20 Harbin Pharmaceutical
        10.1.21 LKPC
    10.2  Active Pharmaceutical Ingredients Sales Date of Major Players (2017-2020e)
        10.2.1 Teva
        10.2.2 Mylan
        10.2.3 DSM
        10.2.4 Aurobindo Pharma
        10.2.5 Aspen
        10.2.6 Novartis
        10.2.7 BASF
        10.2.8 Pfizer
        10.2.9 Huahai Pharmaceutical
        10.2.10 Hisun Pharmaceutical
        10.2.11 Sun Pharmaceutical Industries
        10.2.12 Zhejiang Medicine
        10.2.13 Dr. Reddy’s Laboratories
        10.2.14 Zhejiang NHU
        10.2.15 Bayer
        10.2.16 NCPC
        10.2.17 AbbVie
        10.2.18 Shandong Xinhua Pharmaceutical
        10.2.19 Northeast Pharm
        10.2.20 Harbin Pharmaceutical
        10.2.21 LKPC
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com